Education
About Us
Working with TipRanks
Follow Us
Integral Diagnostics Ltd. (AU:IDX)
ASX:IDX
Total Valuation
Integral Diagnostics Ltd. has a market cap or net worth of AU$924.86M. The enterprise value is AU$1.48B.
Market CapAU$924.86M
Enterprise ValueAU$1.48B
Share Statistics
Integral Diagnostics Ltd. has 372,926,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding372,926,670
Owned by Insiders0.24%
Owned by Institutions―
Financial Efficiency
Integral Diagnostics Ltd.’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 1.82%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.82%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee317.26K
Profits Per Employee0.00
Employee Count1,977
Asset Turnover0.44
Inventory Turnover11.17
Valuation Ratios
The current PE Ratio of Integral Diagnostics Ltd. is 163.2. Integral Diagnostics Ltd.’s PEG ratio is -1.57.
PE Ratio163.2
PS Ratio1.24
PB Ratio1.12
Price to Fair Value1.12
Price to FCF55.58
Price to Operating Cash Flow12.94
PEG Ratio-1.57
Income Statement
In the last 12 months, Integral Diagnostics Ltd. had revenue of 627.22M and earned 4.67M in profits. Earnings per share was 0.02.
Revenue627.22M
Gross Profit599.09M
Operating Income57.53M
Pretax Income11.65M
Net Income4.67M
EBITDA87.70M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 73.77M and capital expenditures -59.76M, giving a free cash flow of 14.01M billion.
Operating Cash Flow73.77M
Free Cash Flow14.01M
Free Cash Flow per Share0.04
Dividends & Yields
Integral Diagnostics Ltd. pays an annual dividend of AU$0.04, resulting in a dividend yield of 2.64%
Dividend Per ShareAU$0.04
Dividend Yield2.64%
Payout Ratio63.73%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-15.17%
50-Day Moving Average2.56
200-Day Moving Average2.52
Relative Strength Index (RSI)41.43
Average Volume (3m)911.20K
Important Dates
Integral Diagnostics Ltd. upcoming earnings date is Feb 25, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
Integral Diagnostics Ltd. as a current ratio of 0.68, with Debt / Equity ratio of 84.42%
Current Ratio0.68
Quick Ratio0.66
Debt to Market Cap0.44
Net Debt to EBITDA6.08
Interest Coverage Ratio2.00
Taxes
In the past 12 months, Integral Diagnostics Ltd. has paid 6.84M in taxes.
Income Tax6.84M
Effective Tax Rate0.59
Enterprise Valuation
Integral Diagnostics Ltd. EV to EBITDA ratio is 14.96, with an EV/FCF ratio of 93.61.
EV to Sales2.09
EV to EBITDA14.96
EV to Free Cash Flow93.61
EV to Operating Cash Flow17.78
Balance Sheet
Integral Diagnostics Ltd. has AU$52.10M in cash and marketable securities with AU$585.01M in debt, giving a net cash position of -AU$532.90M billion.
Cash & Marketable SecuritiesAU$52.10M
Total DebtAU$585.01M
Net Cash-AU$532.90M
Net Cash Per Share-AU$1.43
Tangible Book Value Per Share-AU$0.55
Margins
Gross margin is 26.03%, with operating margin of 9.17%, and net profit margin of 0.75%.
Gross Margin26.03%
Operating Margin9.17%
Pretax Margin1.86%
Net Profit Margin0.75%
EBITDA Margin13.98%
EBIT Margin4.97%
Analyst Forecast
The average price target for Integral Diagnostics Ltd. is AU$3.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$3.22
Price Target Upside29.70% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast33.54%
EPS Growth Forecast―